MACKENZIE FINANCIAL CORP
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 919859
TORONTO ONTARIO, A6
Position in ARWR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,496,768
-$247,232 QoQ
Shares Held
18,363
-34.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#216
of 497 holders
Holding Since
Jun 2021
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $498,673,295 across 59 Biotechnology names. ARWR ranks #39 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
135,783 | $84,666,131 | |
| 2 | INCY |
Incyte Corp
|
634,862 | $71,967,956 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
931,864 | $53,321,258 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,928 | $51,127,425 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
298,440 | $22,227,811 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
985,848 | $16,759,416 | |
| 7 | RPRX |
Royalty Pharma plc
|
270,457 | $15,164,523 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,988 | $13,241,707 |
All Filings in ARWR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,496,768 | 18,363 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,744,000 | 27,815 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $759,833 | 11,445 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $350,970 | 10,176 | Shares | Sole | 2025-11-13 | |
| 2024-12-31 | $137,221 | 7,299 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $208,751 | 7,299 | Shares | Sole | 2024-05-10 | |
| 2023-06-30 | $228,901 | 6,419 | Shares | Sole | 2023-08-03 | |
| 2022-12-31 | $260,354 | 6,419 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $223,351 | 6,758 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $251,821 | 7,152 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $261,545 | 5,687 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $374,528 | 5,649 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $359,159 | 5,753 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $280,345 | 3,385 | Shares | Sole | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||